Dana Boyle Sells 1,238 Shares of Liquidia Technologies (NASDAQ:LQDA) Stock

Key Points

• Dana Boyle, the CAO of Liquidia Technologies, sold 1,238 shares of stock for about $28,981.58, decreasing her position by 0.66% to hold 185,411 shares worth approximately $4.34 million.
• Liquidia Technologies shares traded up 1.7% on Wednesday, reaching $23.16, with a trading volume slightly above its average at nearly 2 million shares.
• Analysts have mixed ratings on the stock, with price targets ranging from $31.00 to $43.00, and a consensus rating of "Moderate Buy."

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 1,238 shares of the firm's stock in a transaction on Monday, October 13th. The stock was sold at an average price of $23.41, for a total value of $28,981.58. Following the transaction, the chief accounting officer owned 185,411 shares in the company, valued at approximately $4,340,471.51. This trade represents a 0.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Dana Boyle also recently made the following trade(s):

• On Monday, July 28th, Dana Boyle sold 1,063 shares of Liquidia Technologies stock. The stock was sold at an average price of $19.54, for a total value of $20,771.02.

Liquidia Technologies Trading Up 1.7%

Shares of Liquidia Technologies stock traded up $0.39 on Wednesday, hitting $23.16. 1,994,182 shares of the company's stock traded hands, compared to its average volume of 1,944,347. The company has a fifty day moving average of $25.00 and a two-hundred day moving average of $18.47. Liquidia Technologies, Inc. has a one year low of $9.71 and a one year high of $29.94. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The company has a market capitalization of $1.99 billion, a price-to-earnings ratio of -13.62 and a beta of 0.15.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). The firm had revenue of $8.84 million for the quarter, compared to analyst estimates of $3.90 million. Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The firm's quarterly revenue was up 141.5% on a year-over-year basis. As a group, sell-side analysts expect that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Institutional Trading of Liquidia Technologies

Institutional investors and hedge funds have recently modified their holdings of the stock. Whitcomb & Hess Inc. boosted its position in Liquidia Technologies by 2.0% during the third quarter. Whitcomb & Hess Inc. now owns 28,385 shares of the company's stock worth $645,000 after acquiring an additional 558 shares during the last quarter. Wedmont Private Capital acquired a new stake in shares of Liquidia Technologies in the 3rd quarter worth $224,000. Advisory Services Network LLC increased its holdings in shares of Liquidia Technologies by 13.2% in the 2nd quarter. Advisory Services Network LLC now owns 76,065 shares of the company's stock valued at $948,000 after purchasing an additional 8,885 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Liquidia Technologies by 281.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company's stock valued at $83,000 after purchasing an additional 4,927 shares in the last quarter. Finally, Exome Asset Management LLC purchased a new position in Liquidia Technologies during the 2nd quarter valued at about $255,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on LQDA shares. Weiss Ratings reissued a "sell (d-)" rating on shares of Liquidia Technologies in a research note on Wednesday, October 8th. HC Wainwright restated a "buy" rating and set a $35.00 price target on shares of Liquidia Technologies in a report on Monday, October 6th. Raymond James Financial lifted their price objective on Liquidia Technologies from $33.00 to $41.00 and gave the company a "strong-buy" rating in a research report on Wednesday, August 13th. Wells Fargo & Company upped their price objective on Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research report on Wednesday, August 13th. Finally, Jefferies Financial Group started coverage on shares of Liquidia Technologies in a research note on Friday, August 15th. They set a "buy" rating and a $43.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $32.38.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.